SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000946644-14-000017
Filing Date
2014-08-08
Accepted
2014-08-08 16:04:26
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q heb-2014063010q.htm 10-Q 820295
2 EXHIBIT heb-20140630xex311.htm EX-31.1 13337
3 EXHIBIT heb-20140630xex312.htm EX-31.2 13403
4 EXHIBIT heb-20140630xex321.htm EX-32.1 6570
5 EXHIBIT heb-20140630xex322.htm EX-32.2 6672
  Complete submission text file 0000946644-14-000017.txt   5641751

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT heb-20140630.xml EX-101.INS 871274
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT heb-20140630.xsd EX-101.SCH 38204
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT heb-20140630_cal.xml EX-101.CAL 52662
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT heb-20140630_def.xml EX-101.DEF 158218
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT heb-20140630_lab.xml EX-101.LAB 482683
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT heb-20140630_pre.xml EX-101.PRE 269140
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27072 | Film No.: 141027504
SIC: 2836 Biological Products, (No Diagnostic Substances)